Reference health
Applications of five-membered ring products of cyclometalation reactions as anticancer agents
46/46 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 46 checked references that resolve
resolves10.1016/j.jorganchem.2007.02.036
Three types of reactions with intramolecular five-membered ring compounds in organic synthesis
resolves10.1002/aoc.1630
Carbonyl group‐containing organometallic intramolecular‐coordination five‐membered ring compounds
resolves10.1039/c3mt00194f
A novel cyclometallated Pt(ii)–ferrocene complex induces nuclear FOXO3a localization and apoptosis and synergizes with cisplatin to inhibit lung cancer cell proliferation
resolves10.1039/b920854b
New 7-azaindole palladium and platinum complexes: crystal structures and theoretical calculations. In vitro anticancer activity of the platinum compounds
resolves10.1021/ed083p192
2005 Nobel Prize in Chemistry. Development of the Olefin Metathesis Method in Organic Synthesis
resolves10.1016/j.ccr.2013.03.024
Anticancer cyclometalated complexes of platinum group metals and gold
resolves10.1039/c1sc00267h
One-step synthesis of composite vesicles: Direct polymerization and in situ over-oxidation of thiophene
resolves10.1039/C2CS35314H
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
resolves10.1021/jm010203d
Mononuclear Platinum(II) Complex with 2-Phenylpyridine Ligands Showing High Cytotoxicity against Mouse Sarcoma 180 Cells Acquiring High Cisplatin Resistance
resolves10.1016/S0162-0134(00)00211-7
Platinum (II) complex with cyclometalating 2-phenylpyridine ligand showing high cytotoxicity against cisplatin-resistant cell
resolves10.1021/jm2006832
In Vitro and In Vivo Antitumor Activities and DNA Binding Mode of Five Coordinated Cyclometalated Organoplatinum(II) Complexes Containing Biphosphine Ligands
resolves10.1016/j.jinorgbio.2011.09.021
Platinum(II) and palladium(II) complexes with (N,N′) and (C,N,N′)− ligands derived from pyrazole as anticancer and antimalarial agents: Synthesis, characterization and in vitro activities
resolves10.1021/ar50125a006
Platinum complexes: probes of polynucleotide structure and antitumor drugs
resolves10.1021/ic991488b
Interaction of [Pt(en)(phen)]<sup>2+</sup> and [Pt(en)(phi)]<sup>2+</sup> with the Hexanucleotide d(GTCGAC)<sub>2</sub>: Evidence for Minor Groove Binding
resolves10.1002/chem.200304964
A Bifunctional Platinum(<scp>II</scp>) Complex Capable of Intercalation and Hydrogen‐Bonding Interactions with DNA: Binding Studies and Cytotoxicity
resolves10.1016/0162-0134(91)80061-L
Synthesis, antimicrobial, and antitumor activity of a series of palladium(II) mixed ligand complexes
resolves10.1002/ejic.200800003
Isolation of an Intermediate in the Platination of <i>p</i>‐Nitroacetophenone 4‐Methylthiosemicarbazone: Potential Application as an Antitumor Drug
resolves10.1021/jm970520d
Novel Tetranuclear Orthometalated Complexes of Pd(II) and Pt(II) Derived from <i>p</i>-Isopropylbenzaldehyde Thiosemicarbazone with Cytotoxic Activity in <i>cis</i>-DDP Resistant Tumor Cell Lines. Interaction of These Complexes with DNA
resolves10.1002/(SICI)1099-0739(199812)12:12<809::AID-AOC754>3.0.CO;2-X
DNA binding andin vitro antileukemic activity of dimeric and tetrameric platinated complexes derived fromp-isopropylbenzaldehyde thiosemicarbazone
resolves10.1016/S0162-0134(99)00021-5
A cycloplatinated compound of p-isopropylbenzaldehyde thiosemicarbazone and its chloro-bridged derivative induce apoptosis in cis-DDP resistant cells which overexpress the H-ras oncogene
resolves10.1016/S0162-0134(99)00102-6
Synthesis and characterization of Pd(II) and Pt(II) complexes of -isopropylbenzaldehyde N-protected thiosemicarbazones. Cytotoxic activity against -transformed cells
resolves10.1016/j.ejmech.2012.06.002
Seven-membered cycloplatinated complexes as a new family of anticancer agents. X-ray characterization and preliminary biological studies
resolves10.1021/om800864f
Five- and Seven-Membered Metallacycles in [C,N,N′] and [C,N] Cycloplatinated Compounds
resolves10.1021/om030674t
Compound [PtPh<sub>2</sub>(SMe<sub>2</sub>)<sub>2</sub>] as a Versatile Metalating Agent in the Preparation of New Types of [C,N,N‘] Cyclometalated Platinum Compounds
resolves10.1021/om00054a031
Competition between intramolecular oxidative addition and ortho metalation in organoplatinum(II) compounds: activation of aryl-halogen bonds
resolves10.1016/j.jorganchem.2012.11.034
Cyclopalladated benzophenone imines: Synthesis, cytotoxicity against human breast adenocarcinoma cell lines and DNA interaction
resolves10.1021/om3006239
Organometallic Palladium Complexes with a Water-Soluble Iminophosphorane Ligand As Potential Anticancer Agents
resolves10.1016/0162-0134(93)85023-2
Synthesis and cytotoxicity of some cyclometallated palladium complexes
resolves10.1021/ic302219v
Novel Bis-C,N-Cyclometalated Iridium(III) Thiosemicarbazide Antitumor Complexes: Interactions with Human Serum Albumin and DNA, and Inhibition of Cathepsin B
resolves10.1039/c3cc46239k
On the antitumor properties of novel cyclometalated benzimidazole Ru(ii), Ir(iii) and Rh(iii) complexes
resolves10.1021/ic201153d
Luminescent Cyclometalated Iridium(III) Polypyridine Di-2-picolylamine Complexes: Synthesis, Photophysics, Electrochemistry, Cation Binding, Cellular Internalization, and Cytotoxic Activity
resolves10.1002/chem.201000474
Modification of Luminescent Iridium(III) Polypyridine Complexes with Discrete Poly(ethylene glycol) (PEG) Pendants: Synthesis, Emissive Behavior, Intracellular Uptake, and PEGylation Properties
resolves10.1002/chem.201200979
Cyclometalated Iridium(III)–Polyamine Complexes with Intense and Long‐Lived Multicolor Phosphorescence: Synthesis, Crystal Structure, Photophysical Behavior, Cellular Uptake, and Transfection Properties
resolves10.1039/c2ra20967e
Iridium(iii) complexes as therapeutic and bioimaging reagents for cellular applications
resolves10.1016/j.biomaterials.2013.06.028
Mitochondria-targeting cyclometalated iridium(III)–PEG complexes with tunable photodynamic activity
resolves10.1039/c1dt10322a
Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: Passing the nanomolar barrier
resolves10.1021/om500001h
Cytotoxicity Studies of Cyclometallated Ruthenium(II) Compounds: New Applications for Ruthenium Dyes
resolves10.1021/ic302779q
Cancer Cell Cytotoxicity of Cyclometalated Compounds Obtained with Osmium(II) Complexes
resolves10.1039/c3sc21972k
A dinuclear cyclometalated gold(iii)–phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo
resolves10.1002/chem.200600117
Anticancer Cyclometalated [Au<sup>III</sup><sub><i>m</i></sub>(C<sup>∧</sup>N<sup>∧</sup>C)<sub><i>m</i></sub>L]<sup><i>n</i>+</sup> Compounds: Synthesis and Cytotoxic Properties
resolves10.1039/c001216e
Cyclometalated gold(iii) complexes with N-heterocyclic carbene ligands as topoisomerase I poisons
resolves10.1021/jm9601563
Antitumor Properties of Some 2-[(Dimethylamino)methyl]phenylgold(III) Complexes
The 5 references without a DOI — listed, not checked
no DOI — not checked10.1016/j.ccr.2014.07.019_bib0005
no DOI — not checked10.1016/j.ccr.2014.07.019_bib0070
no DOI — not checkedM. Peffer, C. Gaiddon, C. Sirlin B. Boff, M. Sidhoum, WO-2013/117870 A1 2013.
no DOI — not checked10.1016/j.ccr.2014.07.019_sbref0145c
no DOI — not checkedC.-M. Che, R.W.-Y. Sun, J. Yan, US, Patent, U.S.-2011/0098264 A1, 2011.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.ccr.2014.07.019"><img src="https://citestamp.com/citestamped/10.1016/j.ccr.2014.07.019/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.ccr.2014.07.019)